GenoMed Inc. (GMED)

[mingwan0]

Articles about Genomed hires

Two articles pick up on the press release, the St Louis Journal:

http://stlouis.bizjournals.com/stlouis/stories/2004/05/10/daily16.html?jst=b_ln_hl

GenoMed names CFO, other executives
GenoMed Inc. has hired three new executives to its management team as it prepares for growth, the company said Tuesday.

Robyn Owens was named chief financial officer, Ellen Jones was named vice president for marketing and Andy O'Guin was named chief technical officer. O'Guin was most recently with a St. Louis biotechnology company. He will oversee research outsourced to GenoMed's partners, the company said.

St. Louis-based GenoMed Inc. (Pink Sheets: GMED) is a medical genomics company working to find genes that cause disease.

And News-Medical.net:

http://www.news-medical.net/view_article.asp?id=1429

GenoMed adds to management team
Posted By: News-Medical in Miscellaneous News
Published: Tuesday, 11-May-2004

GenoMed, Inc., a Next Generation Disease Management™ company that uses its expertise in genes to improve patient outcomes, said today that it has hired three additional full-time employees: a Chief Financial Officer, a Vice President for Marketing, and a Chief Technical Officer.

Ms. Robyn L. Owens was hired as Chief Financial Officer. She has twenty-two years' experience in the health care industry, half on the payor's side and half on the providers' side. Her experience includes contracts, claims, customer service, and bringing private physicians into managed care. Her expertise is in finance, in particular hospital and physician contracting. She is a member of Medical Group Managers Association, Group Health Association of America, and National Association of Female Executives.

Ms. Ellen Jones was hired as Vice President for Marketing. She has experience marketing Internet solutions to banks, tax and regulatory information to accountants and tax lawyers, as well as temporary staffing solutions. She has extensive experience translating complex technical information into everyday language.

Mr. Andy O'Guin was hired as Chief Technical Officer. He comes from a private St. Louis biotechnology company engaged in anti-viral drug discovery. He has experience in genotyping, assay development, and drug discovery. He will oversee research outsourced to GenoMed's partners.

Said Dr. David Moskowitz, GenoMed's CEO and Chairman, "After a careful search, GenoMed now has a wonderful management team, one that is nimble, experienced, and personable. We are poised for growth."